Read + Share
Amedeo Smart
Independent Medical Education
Kumar A, Soumerai JD, Abramson JS, Barnes JA, et al. Zanubrutinib, Obinutuzumab, and Venetoclax for First-Line Treatment of Mantle Cell Lymphoma with a TP53 Mutation. Blood 2024 Oct 22:blood.2024025563. doi: 10.1182/blood.2024025563.PMID: 39437708
Email
LinkedIn
Privacy Policy